| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | regulation of peptide hormone secretion | 1.28e-04 | 277 | 8 | 3 | GO:0090276 | |
| GeneOntologyBiologicalProcess | regulation of peptide transport | 1.35e-04 | 282 | 8 | 3 | GO:0090087 | |
| GeneOntologyBiologicalProcess | regulation of peptide secretion | 1.35e-04 | 282 | 8 | 3 | GO:0002791 | |
| GeneOntologyBiologicalProcess | peptide hormone secretion | 2.22e-04 | 334 | 8 | 3 | GO:0030072 | |
| GeneOntologyBiologicalProcess | peptide secretion | 2.40e-04 | 343 | 8 | 3 | GO:0002790 | |
| GeneOntologyBiologicalProcess | regulation of protein secretion | 2.55e-04 | 350 | 8 | 3 | GO:0050708 | |
| GeneOntologyBiologicalProcess | regulation of hormone secretion | 2.66e-04 | 355 | 8 | 3 | GO:0046883 | |
| GeneOntologyBiologicalProcess | peptide transport | 2.66e-04 | 355 | 8 | 3 | GO:0015833 | |
| GeneOntologyBiologicalProcess | amide transport | 4.35e-04 | 420 | 8 | 3 | GO:0042886 | |
| GeneOntologyBiologicalProcess | hormone secretion | 4.35e-04 | 420 | 8 | 3 | GO:0046879 | |
| GeneOntologyBiologicalProcess | hormone transport | 4.72e-04 | 432 | 8 | 3 | GO:0009914 | |
| GeneOntologyBiologicalProcess | regulation of insulin secretion involved in cellular response to glucose stimulus | 5.41e-04 | 92 | 8 | 2 | GO:0061178 | |
| GeneOntologyBiologicalProcess | protein secretion | 6.43e-04 | 480 | 8 | 3 | GO:0009306 | |
| GeneOntologyBiologicalProcess | establishment of protein localization to extracellular region | 6.55e-04 | 483 | 8 | 3 | GO:0035592 | |
| GeneOntologyBiologicalProcess | insulin secretion involved in cellular response to glucose stimulus | 6.65e-04 | 102 | 8 | 2 | GO:0035773 | |
| GeneOntologyBiologicalProcess | protein localization to extracellular region | 6.83e-04 | 490 | 8 | 3 | GO:0071692 | |
| GeneOntologyBiologicalProcess | regulation of protein transport | 1.01e-03 | 560 | 8 | 3 | GO:0051223 | |
| GeneOntologyBiologicalProcess | positive regulation of peptide hormone secretion | 1.56e-03 | 157 | 8 | 2 | GO:0090277 | |
| GeneOntologyBiologicalProcess | signal release | 1.57e-03 | 653 | 8 | 3 | GO:0023061 | |
| GeneOntologyBiologicalProcess | positive regulation of peptide secretion | 1.64e-03 | 161 | 8 | 2 | GO:0002793 | |
| GeneOntologyBiologicalProcess | regulation of establishment of protein localization | 1.72e-03 | 674 | 8 | 3 | GO:0070201 | |
| GeneOntologyBiologicalProcess | regulation of hormone levels | 1.79e-03 | 684 | 8 | 3 | GO:0010817 | |
| GeneOntologyBiologicalProcess | regulation of secretion by cell | 2.25e-03 | 740 | 8 | 3 | GO:1903530 | |
| GeneOntologyBiologicalProcess | positive regulation of protein secretion | 2.37e-03 | 194 | 8 | 2 | GO:0050714 | |
| GeneOntologyBiologicalProcess | cellular response to glucose stimulus | 2.42e-03 | 196 | 8 | 2 | GO:0071333 | |
| GeneOntologyBiologicalProcess | cellular response to hexose stimulus | 2.50e-03 | 199 | 8 | 2 | GO:0071331 | |
| GeneOntologyBiologicalProcess | cellular response to monosaccharide stimulus | 2.55e-03 | 201 | 8 | 2 | GO:0071326 | |
| GeneOntologyBiologicalProcess | positive regulation of hormone secretion | 2.65e-03 | 205 | 8 | 2 | GO:0046887 | |
| GeneOntologyBiologicalProcess | regulation of secretion | 2.82e-03 | 801 | 8 | 3 | GO:0051046 | |
| GeneOntologyBiologicalProcess | cellular response to carbohydrate stimulus | 2.91e-03 | 215 | 8 | 2 | GO:0071322 | |
| GeneOntologyBiologicalProcess | intracellular glucose homeostasis | 2.99e-03 | 218 | 8 | 2 | GO:0001678 | |
| GeneOntologyBiologicalProcess | regulation of insulin secretion | 3.34e-03 | 231 | 8 | 2 | GO:0050796 | |
| GeneOntologyBiologicalProcess | response to glucose | 4.22e-03 | 260 | 8 | 2 | GO:0009749 | |
| GeneOntologyBiologicalProcess | response to hexose | 4.38e-03 | 265 | 8 | 2 | GO:0009746 | |
| GeneOntologyBiologicalProcess | response to monosaccharide | 4.60e-03 | 272 | 8 | 2 | GO:0034284 | |
| GeneOntologyBiologicalProcess | insulin secretion | 4.67e-03 | 274 | 8 | 2 | GO:0030073 | |
| GeneOntologyBiologicalProcess | response to carbohydrate | 5.61e-03 | 301 | 8 | 2 | GO:0009743 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 2.90e-02 | 718 | 7 | 2 | 28 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#3_top-relative-expression-ranked_500 | 7.97e-06 | 16 | 6 | 2 | gudmap_developingGonad_e16.5_testes_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.13e-04 | 59 | 6 | 2 | gudmap_developingGonad_e16.5_testes_1000_k2 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Neuronal-Cortical_neuron|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 1.74e-05 | 36 | 8 | 2 | 25fd4cf19f2ed94f99600c18383b17f86bb17ef5 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Granulocytic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.96e-04 | 171 | 8 | 2 | b6502a81df4f25660f3ae4b7443a1d999df2d32b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Granulocytic-Mast_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.96e-04 | 171 | 8 | 2 | ac37c80c832504986c7a201d84f4b6aff5e5f323 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.78e-04 | 188 | 8 | 2 | 939790f133eac9c12d08db6ddb5f08f5107844e3 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-41|World / Primary Cells by Cluster | 5.20e-04 | 196 | 8 | 2 | dee0984cd63a1a2fdebb4421af48ab566a5b684e | |
| ToppCell | Caecum-T_cell-Treg|T_cell / Region, Cell class and subclass | 5.30e-04 | 198 | 8 | 2 | 90a2a75ca078f7088b8739795a9b396113bcbe23 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW10-Neuronal|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 5.36e-04 | 199 | 8 | 2 | b2508bf591720830e8e3494b1337aab14539956d | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW09-Neuronal|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 5.41e-04 | 200 | 8 | 2 | e9eb348a66011d8aace4331f84690ae27cb0d061 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal-Cortical_neuron|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 5.41e-04 | 200 | 8 | 2 | 44bc4d6616fc8d0ad8498e56125939034e8cff01 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Neuronal|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 5.41e-04 | 200 | 8 | 2 | 04699d1149a143b96d6f292c0d70c4d3e6dfc611 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 5.41e-04 | 200 | 8 | 2 | 09fd3cb31bcc02444f1045f01fe39bce09359d35 | |
| Drug | 25-hydroxycholesterol | 1.34e-03 | 160 | 8 | 2 | CID000065094 | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 1.54e-03 | 172 | 8 | 2 | 1064_UP | |
| Drug | Apigenin [520-36-5]; Up 200; 14.8uM; HL60; HT_HG-U133A | 1.65e-03 | 178 | 8 | 2 | 1321_UP | |
| Drug | Gossypol [303-45-7]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 1.69e-03 | 180 | 8 | 2 | 3637_UP | |
| Drug | Helveticoside [630-64-8]; Down 200; 7.4uM; PC3; HT_HG-U133A | 1.78e-03 | 185 | 8 | 2 | 4327_DN | |
| Drug | Strophantine octahydrate [11018-89-6]; Down 200; 5.4uM; MCF7; HT_HG-U133A | 1.82e-03 | 187 | 8 | 2 | 2656_DN | |
| Drug | Helveticoside [630-64-8]; Down 200; 7.4uM; PC3; HT_HG-U133A | 1.84e-03 | 188 | 8 | 2 | 3770_DN | |
| Drug | 17-DMAG; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.84e-03 | 188 | 8 | 2 | 1213_DN | |
| Drug | Antimycin A [1397-94-0]; Down 200; 7.2uM; HL60; HG-U133A | 1.84e-03 | 188 | 8 | 2 | 1414_DN | |
| Drug | Hesperetin [520-33-2]; Down 200; 13.2uM; PC3; HT_HG-U133A | 1.86e-03 | 189 | 8 | 2 | 6750_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.86e-03 | 189 | 8 | 2 | 1006_DN | |
| Drug | 5182598; Down 200; 25uM; MCF7; HT_HG-U133A_EA | 1.86e-03 | 189 | 8 | 2 | 976_DN | |
| Drug | 17-AAG; Down 200; 1uM; PC3; HT_HG-U133A | 1.88e-03 | 190 | 8 | 2 | 4442_DN | |
| Drug | 17-AAG; Down 200; 1uM; PC3; HT_HG-U133A | 1.90e-03 | 191 | 8 | 2 | 1225_DN | |
| Drug | Thioperamide maleate [106243-16-7]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 1.90e-03 | 191 | 8 | 2 | 3392_UP | |
| Drug | Cyclobenzaprine hydrochloride [6202-23-9]; Up 200; 12.8uM; HL60; HT_HG-U133A | 1.92e-03 | 192 | 8 | 2 | 1332_UP | |
| Drug | Androsterone [53-41-8]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 1.96e-03 | 194 | 8 | 2 | 5696_DN | |
| Drug | Ornidazole [16773-42-5]; Down 200; 18.2uM; MCF7; HT_HG-U133A | 1.96e-03 | 194 | 8 | 2 | 5483_DN | |
| Drug | Chloramphenicol [56-75-7]; Down 200; 12.4uM; PC3; HT_HG-U133A | 1.96e-03 | 194 | 8 | 2 | 5047_DN | |
| Drug | Procainamide hydrochloride [614-39-1]; Down 200; 14.8uM; PC3; HT_HG-U133A | 1.96e-03 | 194 | 8 | 2 | 4602_DN | |
| Drug | Phthalylsulfathiazole [85-73-4]; Down 200; 10uM; PC3; HT_HG-U133A | 1.98e-03 | 195 | 8 | 2 | 4653_DN | |
| Drug | Fluvastatin sodium salt [93957-55-2]; Up 200; 9.2uM; PC3; HT_HG-U133A | 1.98e-03 | 195 | 8 | 2 | 6691_UP | |
| Drug | Clindamycin hydrochloride [21462-39-5]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 1.98e-03 | 195 | 8 | 2 | 7172_DN | |
| Drug | Prazosin hydrochloride [19237-84-4]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 1.98e-03 | 195 | 8 | 2 | 5416_DN | |
| Drug | Flavoxate hydrochloride [3717-88-2]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 1.98e-03 | 195 | 8 | 2 | 5427_DN | |
| Drug | Ethynodiol diacetate [297-76-7]; Down 200; 10.4uM; PC3; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 6678_DN | |
| Drug | Digoxigenin [1672-46-4]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 3397_DN | |
| Drug | estradiol, USP; Down 200; 0.01uM; ssMCF7; HG-U133A | 2.00e-03 | 196 | 8 | 2 | 373_DN | |
| Drug | Tremorine dihydrochloride [300-68-5]; Down 200; 15uM; MCF7; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 6273_DN | |
| Drug | Esculin Hydrate [531-75-9]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 3390_UP | |
| Drug | Ciprofloxacin hydrochloride [93107-08-5]; Down 200; 10.8uM; PC3; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 6700_DN | |
| Drug | Mepenzolate bromide [76-90-4]; Down 200; 9.6uM; HL60; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 2169_DN | |
| Drug | Nicergoline; Down 200; 8.2uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 6251_DN | |
| Drug | Cefotetan [69712-56-7]; Up 200; 7uM; HL60; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 1319_UP | |
| Drug | Crotamiton [483-63-6]; Down 200; 19.6uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 5689_DN | |
| Drug | chlorpromazine hydrochloride; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 2.02e-03 | 197 | 8 | 2 | 1055_UP | |
| Drug | Pyridoxine hydrochloride [58-56-0]; Down 200; 19.4uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 7171_DN | |
| Drug | aspirin, USP; Down 200; 100uM; PC3; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 1204_DN | |
| Drug | Esculetin [305-01-1]; Up 200; 22.4uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 7459_UP | |
| Drug | Picrotoxinin [17617-45-7]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 2.04e-03 | 198 | 8 | 2 | 2816_DN | |
| Drug | Etofylline [519-37-9]; Down 200; 17.8uM; MCF7; HT_HG-U133A | 2.04e-03 | 198 | 8 | 2 | 5467_DN | |
| Drug | 0179445-0000 [211246-22-9]; Down 200; 1uM; PC3; HT_HG-U133A | 2.04e-03 | 198 | 8 | 2 | 3736_DN | |
| Drug | Prednisolone [50-24-8]; Down 200; 11uM; MCF7; HT_HG-U133A | 2.04e-03 | 198 | 8 | 2 | 5526_DN | |
| Drug | Fluphenazine dihydrochloride [146-56-5]; Down 200; 7.8uM; PC3; HT_HG-U133A | 2.04e-03 | 198 | 8 | 2 | 5880_DN | |
| Drug | Isoxsuprine hydrochloride [579-56-6]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 2.04e-03 | 198 | 8 | 2 | 4789_UP | |
| Drug | L(-)-vesamicol hydrochloride [112709-59-8]; Down 200; 13.6uM; PC3; HT_HG-U133A | 2.04e-03 | 198 | 8 | 2 | 5056_DN | |
| Drug | Bicuculline (+) [485-49-4]; Down 200; 10.8uM; HL60; HT_HG-U133A | 2.04e-03 | 198 | 8 | 2 | 2139_DN | |
| Drug | Naloxone hydrochloride [357-08-4]; Up 200; 11uM; HL60; HG-U133A | 2.04e-03 | 198 | 8 | 2 | 2006_UP | |
| Drug | Tinidazole [19387-91-8]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 2.04e-03 | 198 | 8 | 2 | 4370_DN | |
| Drug | Meprylcaine hydrochloride [956-03-6]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 2.04e-03 | 198 | 8 | 2 | 6204_DN | |
| Drug | Doxepin hydrochloride [1229-29-4]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 2.04e-03 | 198 | 8 | 2 | 7415_DN | |
| Drug | Guanabenz acetate [23256-50-0]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 2.04e-03 | 198 | 8 | 2 | 5703_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 200uM; MCF7; HT_HG-U133A | 2.06e-03 | 199 | 8 | 2 | 6974_UP | |
| Drug | rapamycin, Streptomyces hygroscepicus; Up 200; 0.1uM; MCF7; HT_HG-U133A | 2.06e-03 | 199 | 8 | 2 | 5927_UP | |
| Drug | Lorglumide sodium salt [97964-56-2]; Down 200; 8.4uM; HL60; HT_HG-U133A | 2.06e-03 | 199 | 8 | 2 | 3079_DN | |
| Drug | SR-95639A [115767-94-7]; Down 200; 10uM; PC3; HT_HG-U133A | 2.06e-03 | 199 | 8 | 2 | 6632_DN | |
| Drug | Diprophylline [479-18-5]; Up 200; 15.8uM; PC3; HT_HG-U133A | 2.06e-03 | 199 | 8 | 2 | 1811_UP | |
| Drug | Conessine [546-06-5]; Down 200; 11.2uM; HL60; HT_HG-U133A | 2.06e-03 | 199 | 8 | 2 | 2135_DN | |
| Drug | Eucatropine hydrochloride [536-93-6]; Down 200; 12.2uM; PC3; HT_HG-U133A | 2.06e-03 | 199 | 8 | 2 | 3759_DN | |
| Drug | Glutethimide, para-amino [125-84-8]; Up 200; 17.2uM; MCF7; HT_HG-U133A | 2.08e-03 | 200 | 8 | 2 | 7463_UP | |
| Drug | Allantoin [97-59-6]; Down 200; 25.2uM; MCF7; HT_HG-U133A | 2.08e-03 | 200 | 8 | 2 | 5471_DN | |
| Disease | smoking status measurement | 2.84e-02 | 1160 | 7 | 2 | EFO_0006527 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RCSKDWPCNYDWDSD | 186 | Q9H213 | |
| STWQCPPCDEDWDKD | 96 | Q8WW33 | |
| EKPYKCSWEGCEWRF | 246 | O75840 | |
| YWECKEKQDWSSCPD | 791 | P22059 | |
| ACKDSDWPFCSDEDW | 46 | P02671 | |
| DWPFCSDEDWNYKCP | 51 | P02671 | |
| WKPGDECFALYWEDN | 556 | Q9H7E2 | |
| PWCWYCNRDFDDEKI | 11 | O43670 | |
| FMNYCWCWDLEAGFP | 611 | Q8TDI7 |